AzTrials
AzTrials

AphasiaReadMapNCT06700005

ReadMap: Reading in Stroke Alexia and Typical Aging

An observational study of Aphasia and Stroke, run by Georgetown University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Loss of reading ability due to stroke, called alexia, likely affects over a million Americans at any given time and causes difficulty performing many daily life functions, such as paying bills, using email/text, reading for pleasure, and reading signs in the community. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Aphasia, Stroke, Alexia
How many people
300 participants
Where
1 siteUnited States
Study dates
12 Jan 2023to 31 Aug 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Participants are survivors of left hemisphere stroke with or without reading difficulties, or people with aphasia or alexia due to strokes in other parts of the brain. The investigators recruit participants primarily from the Washington, DC region, but some participants may travel from farther away to participate in the study. The investigators aim for our participants to be fully representative of the diversity of individuals with stroke in the general population. Control participants have not had a stroke or other brain injury, and are matched to stroke survivors on age, gender, race, educational background, and stroke risk factors.

Who may be able to join

  • Stroke Survivors:
  • Age >= 18
  • Learned English at 8 years or younger
  • Brain injury resulting from stroke
  • Controls:
  • Age >= 18
  • Learned English at 8 years or younger

Who cannot join

  • History of other brain disorder that could interfere with our ability to interpret results (e.g., Multiple sclerosis, dementia, head injury causing loss of consciousness)
  • Severe psychiatric condition that would interfere with participation in the study
  • History of diagnosed learning disorder
  • Hearing or vision loss that interferes with performance on behavioral tests even after correction with glasses/hearing aids.
  • Inability to follow study procedures despite maximal support
  • Additional exclusion criteria for MRIs:
Show all 9Show fewer
  • Presence of metal in the body that is incompatible with MRI
  • Pregnancy
  • Claustrophobia

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Alycia Laks, MS, CCC-SLP contact

202-687-5205

crlab@georgetown.edu

United States1 site, 1 recruiting
  • Georgetown University Medical Center

    Washington D.C., District of Columbia, 20057

    Alycia Laks, MS, CCC-SLP, 202-687-5205, crlab@georgetown.edu

    Recruiting

Other trials in United States

About this study

Loss of reading ability due to stroke, called alexia, likely affects over a million Americans at any given time and causes difficulty performing many daily life functions, such as paying bills, using email/text, reading for pleasure, and reading signs in the community. Understanding the brain and cognitive basis of alexia could improve diagnosis and treatment of this important problem. In this study, the investigators will perform a large-scale behavioral and brain imaging study of stroke survivors and typical older adults to improve our understanding of the brain and cognitive basis of reading in both of these groups.

Participants will complete a battery of tests of reading, speech, language, and thinking abilities. In addition, some participants will complete an MRI. Sessions will be completed across approximately 2-6 weeks, but may be extended depending on participants' schedules and availability. Some participants will be invited to repeat these procedures once or twice in approximately 3-12 months to monitor for changes in reading abilities and MRI measurements over time.

Conditions
Aphasia, Stroke, Alexia
Keywords
aphasia, stroke, brain injury, speech, language, reading, alexia, apraxia
Medical subject headings
Aphasia, Stroke, Dyslexia, Brain Injuries, Speech, Language, Apraxias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06700005
Study groupRoleWhat they receive
Stroke SurvivorsParticipants have had a left-hemisphere stroke, or a stroke elsewhere in the brain causing aphasia or alexia (i.e., reading difficulties). They are given a series of standardized and in-house tests of reading, language and cognition to provide a detailed profile of strengths and weaknesses, plus an MRI.
ControlsParticipants are matched to the stroke cohort in age, educational background, race, and gender but have no history of brain injury. They are also given a series of standardized and in-house tests of reading, language and cognition to provide a detailed profile of strengths and weaknesses, plus an MRI.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MP-RAGE (Magnetization Prepared Rapid Acquisition Gradient Echo)

    Part of MRI sequence that measures deep grey matter structure.

    Measured: Collected within 1 month of behavioral testing

  2. DTI (Diffusion Tensor Imaging)

    Part of MRI sequence that measures the rate of water diffusion between cells to understand and create a map of internal structures.

    Measured: Collected within 1 month of behavioral testing

  3. Behavioral testing

    Battery of standard clinical and in-house behavioral tests to measure speech, language, and cognition. Final score is derived from principle components analysis.

    Measured: Collected within 1 month of MRI

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2024
  2. Study start12 Jan 2023
  3. Primary completion31 Aug 2028 (estimated)
  4. Study completion31 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06700005
Sponsor's protocol ID
ReadMap
Other IDs
R01DC020446
Acronym
ReadMap
Status last verified
Oct 2024
First submitted
6 Nov 2024
Last updated
21 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Aphasia and Stroke, run by Georgetown University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alycia Laks, MS, CCC-SLP (202-687-5205, crlab@georgetown.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MP-RAGE (Magnetization Prepared Rapid Acquisition Gradient Echo) (time frame: Collected within 1 month of behavioral testing). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
ReadMap: Reading in Stroke Alexia and Typical Aging | AzTrials